000127332 001__ 127332
000127332 005__ 20240228140919.0
000127332 0247_ $$2doi$$a10.1080/2162402X.2015.1022302
000127332 0247_ $$2WOS$$aWOS:000360239300016
000127332 0247_ $$2ISSN$$a2162-4011
000127332 0247_ $$2ISSN$$a2162-402X
000127332 0247_ $$2altmetric$$aaltmetric:4557276
000127332 0247_ $$2pmid$$apmid:26405578
000127332 037__ $$aDKFZ-2017-03357
000127332 082__ $$a610
000127332 1001_ $$aQiao, Jian$$b0
000127332 245__ $$aIntratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy
000127332 260__ $$aAustin, Tex.$$bLandes Bioscience$$c2015
000127332 3367_ $$2DRIVER$$aarticle
000127332 3367_ $$2DataCite$$aOutput Types/Journal article
000127332 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1525419068_19708
000127332 3367_ $$2BibTeX$$aARTICLE
000127332 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000127332 3367_ $$00$$2EndNote$$aJournal Article
000127332 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000127332 588__ $$aDataset connected to Web of Science, Web of Science, , CrossRef
000127332 7001_ $$aDey, Mahua$$b1
000127332 7001_ $$aChang, Alan L$$b2
000127332 7001_ $$aKim, Julius W$$b3
000127332 7001_ $$aMiska, Jason$$b4
000127332 7001_ $$aLing, Alex$$b5
000127332 7001_ $$0P:(DE-HGF)0$$aM Nettlebeck, Dirk$$b6
000127332 7001_ $$aHan, Yu$$b7
000127332 7001_ $$aZhang, Lingjiao$$b8
000127332 7001_ $$aLesniak, Maciej S$$b9
000127332 773__ $$0PERI:(DE-600)2645309-5$$a10.1080/2162402X.2015.1022302$$gVol. 4, no. 8, p. e1022302 -$$n8$$pe1022302 -$$tOncoImmunology$$v4$$x2162-402X$$y2015
000127332 909CO $$ooai:inrepo02.dkfz.de:127332$$pVDB
000127332 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000127332 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000127332 9141_ $$y2015
000127332 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOIMMUNOLOGY : 2015
000127332 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000127332 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000127332 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000127332 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000127332 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000127332 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000127332 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000127332 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bONCOIMMUNOLOGY : 2015
000127332 9201_ $$0I:(DE-He78)F110-20160331$$kF110$$lOnkolytische Adenoviren$$x0
000127332 980__ $$ajournal
000127332 980__ $$aVDB
000127332 980__ $$aI:(DE-He78)F110-20160331
000127332 980__ $$aUNRESTRICTED